bioAffinity Technologies News

BioAffinity Technologies News Update

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) shares recent Company news. CyPath Lung Sales Ramp Up Month over Month Sales of CyPath Lung, our noninvasive diagnostic test for the early detection

BusinesswireMay 2 20:00

BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

Business WireApr 9 20:00

BioAffinity Technologies Files to Sell 1.63M Shares for Holders

Seeking AlphaApr 5 05:14

BioAffinity Technologies Q4 EPS $(0.26) Up From $(0.44) YoY, Sales $2.21M Down From $2.35M YoY

bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company re

BenzingaApr 2 19:59

Press Release: BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results SAN ANTONIO--(BUSINESS WIRE)--April 01, 2024-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnol

Dow JonesApr 1 21:49

BioAffinity Technologies 4Q Rev $2.2M >BIAF

BioAffinity Technologies 4Q Rev $2.2M >BIAF

Dow JonesApr 1 21:49

BioAffinity (BIAF) Gains Traction In Pre-Market Trading: What's Driving The Momentum?

Recent trading session has witnessed a notable increase in the price of BioAffinity Technologies, Inc. (NASDAQ: BIAF), which has carried over into pre-market activity. Pre-hour trading saw the stock rise 6.40% to $2.16 after closing at $2.03 in the previous session with a significant 32.68% gain. In spite of the lack of instant news, the ...

Stocks TelegraphMar 12 19:53

12 Health Care Stocks Moving In Monday's Intraday Session

GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in

BenzingaMar 12 01:31

BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered

BusinesswireMar 9 01:45

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. Th

BenzingaMar 7 03:35

OCEA, RVSN and HOVR Among Mid-day Movers

Seeking AlphaMar 7 01:50

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersAptorum Gr (NASDAQ:APM) stock moved upwards by 780.6% to $12.77 during Wednesday's regular session. The company's market cap stands at $66.1 million. NKGen Biotech (NASDAQ:NKGN) stock rose 302.

BenzingaMar 7 01:31

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct...

Stockhouse Mar 6 23:45

BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers

Seeking AlphaMar 6 23:00

BioAffinity Technologies Shares Resume Trade

BioAffinity Technologies Shares Resume Trade

BenzingaMar 6 22:56

BioAffinity Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -25.7%

BioAffinity Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -25.7%

BenzingaMar 6 22:47

BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered

BusinesswireMar 6 22:46

BioAffinity Technologies Shares Rise 11% On Surging Sales

By Ben Glickman Shares of BioAffinity Technologies rose Tuesday after the company flagged accelerating sales growth in its test to detect early-stage lung cancer. The stock was up 11% to $2.62 in mi

WSJMar 6 01:43

Regenxbio, Quoin Pharmaceuticals, Renalytix Among Healthcare Movers

Seeking AlphaMar 5 23:02

BioAffinity Reports Surge in Early-stage Lung Cancer Test Orders

bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage cancer and lung disease tests, has reported a significant increase in orders and processing of its CyPath® Lung tests.

Investing.com Mar 5 21:48